Synopsis
Motivation:
Goals:
Approach:
Results:
669-02-009
ISMRM Abstract
MRI histogram and VASARI features for predicting CD163+ tumor-associated macrophages in glioblastomas.
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202. PMID: 36196752; PMCID: PMC9533228. [doi] [pmid]
2. Wang LJ, Xue Y, Lou Y. Tumor-associated macrophages related signature in glioma. Aging (Albany NY). 2022 Mar 24;14(6):2720-2735. doi: 10.18632/aging.203968. Epub 2022 Mar 24. PMID: 35332109; PMCID: PMC9004565. [doi] [pmid]
3. Idoate Gastearena MA, López-Janeiro Á, Lecumberri Aznarez A, Arana-Iñiguez I, Guillén-Grima F. A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma. Biomedicines. 2022 Jul 21;10(7):1753. doi: 10.3390/biomedicines10071753. PMID: 35885058; PMCID: PMC9313250. [doi] [pmid]
4. Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci. 2020 Jul 31;21(15):5497. doi: 10.3390/ijms21155497. PMID: 32752088; PMCID: PMC7432735. [doi] [pmid]
5. Pires-Afonso Y, Niclou SP, Michelucci A. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma. Int J Mol Sci. 2020 Jan 21;21(3):689. doi: 10.3390/ijms21030689. PMID: 31973030; PMCID: PMC7037936. [doi] [pmid]
6. Wang X, Xu Y, Sun Q, Zhou X, Ma W, Wu J, Zhuang J, Sun C. New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. Biomed Pharmacother. 2022 Sep;153:113343. doi: 10.1016/j.biopha.2022.113343. Epub 2022 Jul 1. PMID: 35785706. [doi] [pmid]
7. Idoate Gastearena MA, López-Janeiro Á, Lecumberri Aznarez A, Arana-Iñiguez I, Guillén-Grima F. A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma. Biomedicines. 2022 Jul 21;10(7):1753. doi: 10.3390/biomedicines10071753. PMID: 35885058; PMCID: PMC9313250. [doi] [pmid]
8. Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci. 2020 Jul 31;21(15):5497. doi: 10.3390/ijms21155497. PMID: 32752088; PMCID: PMC7432735. [doi] [pmid]
9. Xue C, Zhou Q, Zhang P, Zhang B, Sun Q, Li S, Deng J, Liu X, Zhou J. MRI histogram analysis of tumor-infiltrating CD8+ T cell levels in patients with glioblastoma. Neuroimage Clin. 2023;37:103353. doi: 10.1016/j.nicl.2023.103353. Epub 2023 Feb 18. PMID: 36812768; PMCID: PMC9958466. [doi] [pmid]
10. Zhang B, Zhou Q, Zhang P, Xue C, Ke X, Wang Y, Han T, Zhou F, Dong W, Deng L, Jing M, Zhang Y, Liu X, Zhou J. MRI histogram and Visually AcceSAble Rembrandt Images features nomogram to predict PD-L1 levels in glioblastoma. Neurosurg Rev. 2025 Apr 21;48(1):371. doi: 10.1007/s10143-025-03528-8. PMID: 40257668. [doi] [pmid]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/669-02-009